NovaBay Pharmaceuticals, Inc.

NYSE:NBY

Pharmaceutical Preparations·EMERYVILLE, CA

CEO

Kazley Michael John

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/7/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	4/2/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

Earnings Releases (8-K)

4 shown

Filed	Period
10/16/24	Q3 FY2024	→
7/11/24	Q2 FY2024	→
3/14/24	Q1 FY2024	→
7/21/20	Q2 FY2020	→

News (8-K)

76 shown

Filed	Type	Description
2/20/26	Other	Material Modification to Rights of Security Holders	→
2/12/26	Other	Other Events	→
1/30/26	Other	Changes in Registrant's Certifying Accountant	→
1/28/26	Other	Changes in Registrant's Certifying Accountant	→
1/20/26	Agreement	Entry into a Material Definitive Agreement	→
1/16/26	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/20/26	424B5	424B5	→
11/25/25	S-8	S-8	→
11/25/25	S-3/A	FORM S-3/A	→
10/3/25	S-3	S-3	→
9/23/25	ARS	ARS	→
7/29/24	424B4	424B4	→
↓

Filing History(1002 filings)

TypeDateAccessionPeriodSize

DEFA14A

Mar 2, 2026

0001437749-26-006407FORM DEFA14A

—

34.0 KB

8-K

Feb 20, 2026

0001437749-26-004922FORM 8-K

Feb 20, 2026

170.8 KB

8-K

Feb 12, 2026

0001437749-26-003846FORM 8-K

Feb 11, 2026

179.1 KB

DEF 14A

Feb 10, 2026

0001437749-26-003571FORM DEF 14A

Mar 12, 2026

749.6 KB

8-K

Jan 30, 2026

0001437749-26-002586FORM 8-K

Jan 30, 2026

163.2 KB

PRE 14A

Jan 30, 2026

0001437749-26-002582FORM PRE 14A

Mar 12, 2026

749.7 KB

SCHEDULE 13D/A

Jan 29, 2026

0001829126-26-000773

—

7.4 KB

Jan 29, 2026

0000921895-26-000165OWNERSHIP DOCUMENT

Oct 21, 2025

8.4 KB

8-K

Jan 28, 2026

0001437749-26-002309FORM 8-K

Jan 22, 2026

197.6 KB

Jan 27, 2026

0001389545-26-000001

—

5.9 KB

SCHEDULE 13D/A

Jan 21, 2026

0001437749-26-001671

—

18.0 KB

SCHEDULE 13D/A

Jan 21, 2026

0001437749-26-001670

—

15.7 KB

8-K

Jan 20, 2026

0001437749-26-001490FORM 8-K

Jan 20, 2026

478.0 KB

424B5

Jan 20, 2026

0001437749-26-001489FORM 424B5

—

487.0 KB

8-K

Jan 16, 2026

0001437749-26-001459FORM 8-K

Jan 16, 2026

1.1 MB

EFFECT

Nov 26, 2025

9999999995-25-003396

—

1.7 KB

S-8

Nov 25, 2025

0001437749-25-036357FORM S-8

—

243.8 KB

S-3/A

Nov 25, 2025

0001437749-25-036354FORM S-3/A

—

653.0 KB

10-Q

Nov 7, 2025

0001437749-25-033852FORM 10-Q

Sep 30, 2025

11.7 MB

Nov 3, 2025

0001437749-25-032856FORM 4

Oct 16, 2025

15.1 KB

Nov 3, 2025

0001437749-25-032855FORM 4

Oct 16, 2025

13.5 KB

Nov 3, 2025

0001437749-25-032854FORM 4

Oct 16, 2025

9.0 KB

4/A

Oct 22, 2025

0001829126-25-008355FORM 4A

Oct 16, 2025

33.8 KB

3/A

Oct 22, 2025

0001829126-25-008354FORM 3A

Oct 9, 2025

30.4 KB

8-K

Oct 22, 2025

0001829126-25-0083388-K

Oct 16, 2025

322.5 KB

25 filings shown

NovaBay Pharmaceuticals, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1002 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/2/26	DEFA14A	FORM DEFA14A	→
2/10/26	DEF 14A	DEF 14A	→
1/30/26	PRE 14A	FORM PRE 14A	→
10/9/25	DEFA14A	DEFA14A	→
9/23/25	DEF 14A	DEF 14A	→
9/18/25	DEFA14A	DEFA14A	→
↓

Filed	Form	Description
1/29/26	4	OWNERSHIP DOCUMENT	→
11/3/25	4	4	→
11/3/25	4	4	→
11/3/25	4	4	→
10/22/25	4/A	FORM 4A	→
10/22/25	3/A	FORM 3A	→
↓